# Digital Inclination to drive the Uveitis Market
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2021-11-29
Category: Research Reports
Category URL: https://financedigest.com/category/research-reports
Meta Title: IoMT Transforming Healthcare: Future of Uveitis Market
Meta Description: Discover how the Uveitis Market is evolving with tech-driven innovations and precision medicine, leading to improved healthcare for patients. Learn more here!
URL: https://financedigest.com/digital-inclination-to-drive-the-uveitis-markethtml

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-2-1736836835966-compressed.jpg)

The Uveitis Market is slated to witness exponentiation going forward. The IoMT (Internet-of-Medical-Things) is already [transforming every walk](https://www.financedigest.com/the-d-mannose-market-to-walk-through-digital-transformation-stampede.html "The D-Mannose Market To Walk Through Digital Transformation Stampede") of life, including healthcare. Healthcare IT has let both – patients and doctors carry/download information about each other anywhere and anytime through their smartphones/tabs. In other words, more connectivity translates to better access to data, thereby rendering better healthcare for patients. This would be the [future of the healthcare](https://www.financedigest.com/the-future-of-healthcare.html "The future of healthcare") vertical in the upcoming period.

The [**Uveitis Market**](https://www.persistencemarketresearch.com/market-research/uveitis-market.asp) is expected to reach **US$ 840 Million** at a **CAGR of 6.5%** from 2024. Tech-driven innovation is the trend that the healthcare vertical would be resting on in the [forecast period](https://www.financedigest.com/synthetic-gypsum-market-expanding-at-a-cagr-of-over-5-during-the-forecast-period-of-2020-2030.html "Synthetic Gypsum Market Expanding At A CAGR Of Over 5% During The Forecast Period Of 2020-2030"). With precision medicine being the focal point, extensive research is being carried out in every arm of the healthcare vertical. The [status quo](https://www.financedigest.com/pelosi-praises-taiwan-says-asian-trip-wasnt-to-change-status-quo.html "Pelosi praises Taiwan, says Asian trip wasn’t to change status quo") is expected to stay unchanged even in the forecast period.

The US$ 497 Mn uveitis [treatment market](https://www.financedigest.com/constructive-digitization-to-drive-the-non-infectious-macular-edema-treatment-market.html "Constructive Digitization to drive the Non Infectious Macular Edema Treatment Market") is likely to expand at a stable **CAGR of 6.5%** over the next eight years. In 2017, the [market is expected to witness](https://www.financedigest.com/the-underwear-market-to-witness-calculated-innovation.html "The Underwear Market To Witness Calculated Innovation") nearly 6.7% Y-o-Y growth over 2016. During 2016-2024, Persistence Market Research predicts a positive **[growth outlook for the global uveitis treatment](https://www.financedigest.com/the-uveitis-treatment-market-to-join-the-growth-adsorption-spectrum.html "The Uveitis Treatment Market to join the growth adsorption spectrum") market**, influenced by several growth drivers, restraints, trends, and opportunities.

In its recently published report titled “ **Uveitis Treatment Market:** Industry Analysis and Forecast, 2016–2024,” the company provides in-depth analysis of the market growth prospects for the eight-year assessment period, [backing it up with historic and current market](https://www.financedigest.com/analysis-bond-traders-get-their-swagger-back-in-rate-obsessed-markets.html "Analysis-Bond traders get their swagger back in rate-obsessed markets") data.

**Want Insights To Uveitis Market? Ask For Sample!** **https://www.persistencemarketresearch.co/samples/3596**

**Company Profiles**

- Allergan, Inc.,
- Bausch & Lomb Incorporated.
- Novartis AG (Alcon Laboratories Inc.)
- AbbVie Inc.
- Santen Pharmaceutical Co., Ltd
- Eyegate Pharmaceuticals, Inc.
- Alimera Sciences, Inc.
- pSivida Corp.

**Get A Customized Scope To Match Your Need Ask An Expert –** [**sales@persistencemarketresearch.com**](mailto:msales@persistencemarketresearch.com)

**Planning To Conclude Your Strategy On A Decisive Note In The Uveitis Market? Glance Through The “Methodology” Implied!** **https://www.persistencemarketresearch.co/methodology/3596**

**Persistence Market Research identified a few important drivers and trends that will [continue to present attractive growth](https://www.financedigest.com/multilocal-hires-new-directors-as-steep-growth-trajectory-continues.html "Multilocal hires new directors as steep growth trajectory continues") opportunities during 2016-2024.**

While surge in autoimmune disorders is identified to primarily generate the demand for uveitis, the market has been witnessing strong emergence of immunosuppressive therapies to treat uveitis since the past few years, which is expected to [create a new set of opportunities](https://www.financedigest.com/digitalisation-why-using-the-opportunity-of-fintechs-can-create-an-innovative-digital-client-experience.html "Digitalisation: why using the opportunity of Fintechs can create an innovative digital client experience") for leading players in near future.

“ _Some_ _of the [leading companies](https://www.financedigest.com/infrared-thermometer-market-2021-global-leading-companies-analysis-revenue-trends-and-forecasts-2026.html "Infrared Thermometer Market 2021 Global Leading Companies Analysis, Revenue, Trends and Forecasts 2026") in the uveitis treatment marketplace have been investing in new, improved product launches since the past decade_. While a significant number of uveitis [drugs are already in the pipeline](https://www.financedigest.com/gsk-bets-2-billion-on-bellus-cough-drug-to-soothe-pipeline-fears.html "GSK bets  billion on Bellus cough drug to soothe pipeline fears"), increasing in-licensing approvals for new market entrants will boost the scope of treatment against uveitis, ultimately creating new lucrative opportunities,” states Persistence Market Research.

- Increasing demand for generic drugs also prompt at an [important trend in the global](https://www.financedigest.com/the-importance-of-global-collaboration-in-the-edtech-sector.html "The importance of global collaboration in the EdTech sector") uveitis treatment market that will reportedly generate a range of opportunities for established as well as new pharma players.
- In addition to growing R&D activities in the field of eye disorders, rising optometric [clinical practice will also provide an impetus to market](https://www.financedigest.com/the-clinical-nutrition-market-to-escalate-on-a-holistic-note.html "The Clinical Nutrition Market To Escalate On A Holistic Note") growth.
- With surging uveitis prevalence, a host of biological drug [development projects](https://www.financedigest.com/cordant-projects-to-develop-eleven-moxy-hotels-across-uk.html "Cordant Projects to develop Eleven Moxy Hotels across UK") is anticipated to push the potential of the uveitis treatment market.
- Moreover, growing prevalence of TB associated with intermediate uveitis will continue to push the opportunities in intermediate uveitis segment.
- Another [proliferating trend in uveitis treatment market](https://www.financedigest.com/the-peptic-ulcer-drugs-market-to-proliferate-with-digitized-upswing.html "The Peptic Ulcer Drugs Market to proliferate with digitized upswing") includes increasing demand for local steroid implants, especially for non-infectious posterior uveitis.
- As corticosteroid mono-therapy is no more considered the first line treatment for uveitis, the market has been witnessing introduction of various modified [**corticosteroid**](https://www.persistencemarketresearch.com/market-research/corticosteroid-market.asp) medication and drug delivery methods since the recent past.
- Major players in the segment are [working to add novel drugs to their product](https://www.financedigest.com/the-psychology-of-long-term-remote-working-productivity-vs-inclusivity.html "The psychology of long-term remote working: Productivity vs. Inclusivity") portfolio.
- R&D in topical agents segment will also benefit the market [growth in near future](https://www.financedigest.com/portugals-q3-growth-accelerates-with-consumption-but-future-not-shining.html "Portugal’s Q3 growth accelerates with consumption but future not shining").

**How About Knowing The Product/Technology Driving The Uveitis Market Before Investing Therein? Click The “Purchase Now” Button Of Our Uveitis Market Report!** [**https://www.persistencemarketresearch.com/checkout/3596**](https://www.persistencemarketresearch.com/checkout/3596)

**Segmentation by treatment type:**

- Corticosteroids
- Immunosuppressants
- Monoclonal antibodies
- Cycloplegic agents
- Antibodies
- Antivirals
- Antifungals
- Analgesics

Corticosteroids will remain the largest segment, followed by antibiotics and monoclonal antibodies. While corticosteroids segment is foreseen to account for a dominant market share of over 21% in 2024, antibiotics segment is expected to [witness the fastest growth at a CAGR](https://www.financedigest.com/pcb-design-software-market-to-witness-an-attractive-cagr-of-15.html "PCB Design Software Market to witness an attractive CAGR of 15%") of 8% – reaching beyond US$ 146 Mn over 2016-2024. Monoclonal antibodies segment will also [exhibit healthy growth at a CAGR](https://www.financedigest.com/iv-bag-market-projected-to-exhibit-a-high-single-digit-cagr-through-2027.html "IV Bag Market Projected to Exhibit a High Single-Digit CAGR through 2027") of 7%, reaching revenues worth US$ 142.7 Mn by the end of 2024.

**Segmentation by disease type:**

- Anterior uveitis
- Posterior uveitis
- Intermediate uveitis
- Panuveitis

Anterior uveitis segment will continue to dominate. Through 2024, this segment will capture around 60% value share, representing a value of over US$ 500 Mn. Posterior uveitis is also estimated for a considerable [market value](https://www.financedigest.com/scissor-lifts-market-to-reach-a-value-of-us-4-5-bn-by-2031.html "Scissor Lifts Market to reach a value of ~US$ 4.5 Bn by 2031.") share of over 23% in 2024. Attributed to increased prevalence of TB in intermediate uveitis, the intermediate uveitis will possibly be the second fastest growing segment over the [forecast period](https://www.financedigest.com/servo-press-market-to-register-a-robust-growth-rate-during-the-forecast-period-2017-2025.html "Servo Press Market to Register a Robust Growth Rate During the Forecast Period 2017 – 2025").

**About us:** [**Persistence Market Research**](https://www.persistencemarketresearch.com/about-us.asp)

**Contact us:**

**[Persistence Market](https://www.financedigest.com/persistence-innovation-to-replenish-the-novel-sweeteners-market.html "Persistence Innovation To Replenish The Novel Sweeteners Market") Research**

Address – 305 Broadway, 7th Floor, New York City,

NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

**Sales** – sales@persistencemarketresearch.com


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---